Demegen
1992
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
4
FINANCING ROUNDS
1
INVESTMENTS
Description
Developer of peptides for the treatment and prevention of infections caused due to multi drug resistant bacteria and fungi. The company develops products for the treatment of dermatological, vaginal, respiratory, ophthalmic and oral diseases with the peptides bind to and kill harmful microorganisms.
Website
Formerly Known As
Demeter BioTechnologies
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Par Advance Technologies
Primary Office
- 100 Technology Drive
- Suite 440B
- Pittsburgh, PA 15219
- United States
Demegen Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Demegen‘s full profile, request access.
Request full access to PitchBookDemegen Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000000 | 01-Jan-2001 | 000000000000000000 | Other Pharmaceuticals and Biotechnology |
Demegen Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Demegen‘s full profile, request access.
Request full access to PitchBook